ARTICLE | Finance
Venture Report: Megarounds for BridgeBio newco, Pathalys and the latest from Versant
$300M raise for rare disease company GondolaBio headlines the week’s biggest venture rounds
August 22, 2024 10:43 PM UTC
A new spinout from BridgeBio led a trio of biotechs announcing access to nine-figure sums this week.
GondolaBio LLC has drawn $300 million from a crossover syndicate to advance programs targeting three rare diseases, including at least one that has entered the clinic...